Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep734 | Adrenal and Cardiovascular Endocrinology | ECE2024

Hydrocortisone vs prednisolone for treatment of adrenal insufficiency disease (HYPER-AID Study) – interim results from a single, tertiary care centre

Maria Leca Bianca , Thadani Puja , Dineesha Kumarathunga Dineesha , Wellala Vindya , Davasgaium Allan , George Rojet , Seehra Parminder , Mattu Rajan , Randeva Harpal S.

Introduction: Adrenal insufficiency (AI) requires lifelong steroid replacement therapy, traditionally with hydrocortisone (HC), which, taken in divided doses, mimics the normal daytime cortisol profile. Prednisolone, with its longer duration of action, presents a cost-effective, once-daily alternative, yet its comparative efficacy and safety profile in AI management still need to be explored. Therefore, the current study aims to assess the metabolic and cardiovascular outcomes...